Inquis Medical announced today that it completed enrollment in a pivotal trial evaluating its Aventus thrombectomy system.

The mechanism in the AngioJet rheolytic thrombectomy (RT) system (Figure 1) involves the delivery of pressurized heparinized saline from the catheter, where saline jets travel backwards creating a ...

A Dutch trial showed that performance feedback via a dashboard reduced door-to-groin and door-to-needle times in patients ...

Inquis Medical, which is developing therapies for venous thromboembolic diseases, announced the completion of patient ...

Argon Medical Devices, a leading provider of device solutions for Interventional Radiology, Vascular Surgery, Interventional ...

Argon Medical Devices announced the first patient enrollment in the CLEAN-PE study, which is estimated to enroll > 100 patien ...

Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the deal at $4.9 billion.

With full enrollment completed, the company is one step closer to demonstrating the potential of the Aventus Thrombectomy System to revolutionize PE treatment. “This trial is a key step toward ...

for its ClotTriever Thrombectomy System for DVT. This announcement follows the regulatory approval of the ClotTriever system by the Pharmaceuticals and Medical Devices Agency (PMDA) in December 2023.